The SyncroPatch 384 is installed at the FDA for cardiac safety pharmacology studies
Nanion is pleased to announce that a SyncroPatch 384 instrument has been installed at the Food and Drug Administration (…
Nanion is pleased to announce that a SyncroPatch 384 instrument has been installed at the Food and Drug Administration (…
Deutliche Verbesserung des operativen Ergebnisses im 3. Quartal 2020 gegenüberVorquartal Erfolgreiche Einleitung vo…
Effizienzprogramm „Transform for Growth“ konkretisiert und eingeleitet – jährliche Kosteneinsparung von rund 100 Million…
◼ Rückgang des operativen Ergebnisses und der entsprechenden Gewinnmarge ◼ Weiterhin positive Entwicklung des margenstar…
Dr. Costantin has a solid and highly impressive track record in customer relation management, in-depth knowledge of ion…
Nanion Technologies, an innovative German-based company providing high quality devices for ion channel research and drug…
The SyncroPatch 384/768PE offers the highest throughput in automated patch clamping history. The SyncroPatch 384/768PE f…
The SyncroPatch 96, a high quality, high throughput patch clamp ion channel screening platform, shows impressive results…
Nanion gibt heute die Eröffnung seiner US-Tochter Nanion Technologies Inc. in North Brunswick, NJ bekannt. Nanion verstä…
Nanion today announces the opening of Nanion Technologies Inc. with headquarters in North Brunswick, NJ, USA. To support…